References
- INAHTA. International Network of Agencies for Health Technology Assessment. 2014. Available from: www.inahta.net/ [Last accessed 23 November 2014]
- Altenstetter C. EU and member state medical devices regulation. Int J Technol Assess Health Care 2003;19:228-48
- Driving Factors for Home Used Medical Devices. Unique facts about Home Used Medical Devices. 2014. Available from: http://homeusemedicaldevices.com/ [Last accessed 23 November 2014]
- Basheti IA, Reddel HK, Armour CL, et al. Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care 2005;50:617-23
- Bosnic-Anticevich SZ, Sinha H, So S, et al. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma 2010;47:251-6
- Kaae S, Søndergaard B, Haugbølle LS, et al. Sustaining delivery of the first publicly reimbursed cognitive service in Denmark: a cross-case analysis. Int J Pharm Pract 2010;18:21-7
- Tack C, Pohlmeier H, Behnke T, et al. Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a european multicenter study with 453 subjects. Diabetes Technol Ther 2012;14:330-7
- Negru DS, Diaconescu M, Petculescu AM, et al. Community pharmacy–ideal location to screen and monitor hypertensive patients. Rev Med Chir Soc Med Nat Iasi 2010;114:904-9
- Karwalajtys T, Kaczorowski J, Hutchison B, et al. Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme. J Hum Hypertens 2009;23:585-9
- Pallikarakis N, Moore R. Health care in Europe. Regulatory framework and industry perspectives of the “New approach”. IEEE Eng Med Biol Mag 2007;26(3):14-17
- Wilkinson J. Medical technology in Europe. Eucomed Medical Technology, Brussels; 2009
- Sorenson C, Kanavos P. Medical technology procurement in Europe: A cross-country comparison of current practice and policy. Health Policy 2011;100:43-50
- Volmer D, Bell JS, Janno R, et al. Change in public satisfaction with community pharmacy services in Tartu, Estonia, between 1993 and 2005. Res Social Adm Pharm 2009;5:337-46
- Medical Device Regulations. Global Overview and Guiding Principles. Geneva: WHO; 2003
- Kjome RLS, Sandberg S, Granas AG. Diabetes care in Norwegian pharmacies: a descriptive study. Pharm World Sci 2008;30:191-8
- Müller U, Hämmerlein A, Casper A, Schulz M. Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patients. Pharm Pract 2006;4:195-203
- Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki T. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open 2013;3:e003154
- Ali M, Schifano F, Robinson P, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med 2012;29:326-e333
- Self-evaluation report. Department of Pharmacy, Faculty of medicine, University of Tartu. Available from: www.farmaatsia.ut.ee/sites/default/files/www_ut/akrediteerimine_final.pdf [Last accessed 20 March 2015]
- The Council Directive 93/42/EEC on Medical Devices. 1993. Available from: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1993L0042:20071011:EN:PDF [Last accessed 23 November 2014]